LTF and necrotizing enterocolitis: A recently published Italian multicentre trial examined whether enteral supplementation with exogenous (bovine) lactoferrin for up to 6 weeks, either alone or in combination with a probiotic Lactobacillus, reduced the risk of NEC and invasive nosocomial infection in VLBW infants.